• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Biosimilar Monoclonal Antibodies Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

report cover
  • 2 September 2020
  • Healthcare
  • 116 Pages
  • Report Code: 24LS-21328
  • Formate :   
Download FREE Report Sample Download PDF File

Biosimilar Monoclonal Antibodies -MARKET ADVISORY SERVICES

Biosimilar Monoclonal Antibodies market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Biosimilar Monoclonal Antibodies market is segmented into
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

Segment by Application, the Biosimilar Monoclonal Antibodies market is segmented into
Oncology
Autoimmune Disease
Other

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Biosimilar Monoclonal Antibodies Market Share Analysis
Biosimilar Monoclonal Antibodies market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Biosimilar Monoclonal Antibodies product introduction, recent developments, Biosimilar Monoclonal Antibodies sales by region, type, application and by sales channel.

The major companies include:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
1 Study Coverage
1.1 Biosimilar Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Biosimilar Monoclonal Antibodies Market Size Estimates and Forecasts
2.1.1 Global Biosimilar Monoclonal Antibodies Revenue 2015-2026
2.1.2 Global Biosimilar Monoclonal Antibodies Sales 2015-2026
2.2 Biosimilar Monoclonal Antibodies Market Size by Region: 2020 Versus 2026
2.3 Biosimilar Monoclonal Antibodies Sales by Region (2015-2026)
2.3.1 Global Biosimilar Monoclonal Antibodies Sales by Region: 2015-2020
2.3.2 Global Biosimilar Monoclonal Antibodies Sales Forecast by Region (2021-2026)
2.3.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2026)
2.4 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Biosimilar Monoclonal Antibodies Revenue by Region: 2015-2020
2.4.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2021-2026)
2.4.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2026)

3 Global Biosimilar Monoclonal Antibodies by Manufacturers
3.1 Global Top Biosimilar Monoclonal Antibodies Manufacturers by Sales
3.1.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2015-2020)
3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Biosimilar Monoclonal Antibodies Manufacturers by Revenue
3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2015-2020)
3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturer (2015-2020)
3.3 Global Biosimilar Monoclonal Antibodies Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Biosimilar Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
3.4.2 Global Biosimilar Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Product Type
3.5.1 Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Biosimilar Monoclonal Antibodies Product Type
3.5.3 Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 Celltrion
4.1.1 Celltrion Corporation Information
4.1.2 Celltrion Description, Business Overview
4.1.3 Celltrion Biosimilar Monoclonal Antibodies Products Offered
4.1.4 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Celltrion Biosimilar Monoclonal Antibodies Revenue by Product
4.1.6 Celltrion Biosimilar Monoclonal Antibodies Revenue by Application
4.1.7 Celltrion Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.1.8 Celltrion Biosimilar Monoclonal Antibodies Revenue by Sales Channel
4.1.9 Celltrion Recent Development
4.2 Pfizer (Hospira)
4.2.1 Pfizer (Hospira) Corporation Information
4.2.2 Pfizer (Hospira) Description, Business Overview
4.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered
4.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue by Product
4.2.6 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue by Application
4.2.7 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.2.8 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue by Sales Channel
4.2.9 Pfizer (Hospira) Recent Development
4.3 3SBIO
4.3.1 3SBIO Corporation Information
4.3.2 3SBIO Description, Business Overview
4.3.3 3SBIO Biosimilar Monoclonal Antibodies Products Offered
4.3.4 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.3.5 3SBIO Biosimilar Monoclonal Antibodies Revenue by Product
4.3.6 3SBIO Biosimilar Monoclonal Antibodies Revenue by Application
4.3.7 3SBIO Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.3.8 3SBIO Biosimilar Monoclonal Antibodies Revenue by Sales Channel
4.3.9 3SBIO Recent Development
4.4 Novartis (Sandoz)
4.4.1 Novartis (Sandoz) Corporation Information
4.4.2 Novartis (Sandoz) Description, Business Overview
4.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered
4.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue by Product
4.4.6 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue by Application
4.4.7 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.4.8 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue by Sales Channel
4.4.9 Novartis (Sandoz) Recent Development
4.5 Dr Reddy’s
4.5.1 Dr Reddy’s Corporation Information
4.5.2 Dr Reddy’s Description, Business Overview
4.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Products Offered
4.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Dr Reddy’s Biosimilar Monoclonal Antibodies Revenue by Product
4.5.6 Dr Reddy’s Biosimilar Monoclonal Antibodies Revenue by Application
4.5.7 Dr Reddy’s Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.5.8 Dr Reddy’s Biosimilar Monoclonal Antibodies Revenue by Sales Channel
4.5.9 Dr Reddy’s Recent Development
4.6 Celgen Biopharma
4.6.1 Celgen Biopharma Corporation Information
4.6.2 Celgen Biopharma Description, Business Overview
4.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered
4.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue by Product
4.6.6 Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue by Application
4.6.7 Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.6.8 Celgen Biopharma Recent Development
4.7 Cadila Healthcare
4.7.1 Cadila Healthcare Corporation Information
4.7.2 Cadila Healthcare Description, Business Overview
4.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered
4.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue by Product
4.7.6 Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue by Application
4.7.7 Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.7.8 Cadila Healthcare Recent Development
4.8 Hisun Pharma
4.8.1 Hisun Pharma Corporation Information
4.8.2 Hisun Pharma Description, Business Overview
4.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered
4.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.8.5 Hisun Pharma Biosimilar Monoclonal Antibodies Revenue by Product
4.8.6 Hisun Pharma Biosimilar Monoclonal Antibodies Revenue by Application
4.8.7 Hisun Pharma Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.8.8 Hisun Pharma Recent Development
4.9 Torrent Pharmaceuticals
4.9.1 Torrent Pharmaceuticals Corporation Information
4.9.2 Torrent Pharmaceuticals Description, Business Overview
4.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered
4.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue by Product
4.9.6 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue by Application
4.9.7 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue by Geographic Area
4.9.8 Torrent Pharmaceuticals Recent Development

5 Breakdown Data by Type
5.1 Global Biosimilar Monoclonal Antibodies Sales by Type (2015-2026)
5.1.1 Global Biosimilar Monoclonal Antibodies Sales by Type (2015-2020)
5.1.2 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2021-2026)
5.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2026)
5.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2015-2026)
5.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020)
5.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2021-2026)
5.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2015-2026)
5.3 Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Biosimilar Monoclonal Antibodies Sales by Application (2015-2026)
6.1.1 Global Biosimilar Monoclonal Antibodies Sales by Application (2015-2020)
6.1.2 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2021-2026)
6.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2026)
6.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2015-2026)
6.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Application (2015-2020)
6.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2021-2026)
6.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2015-2026)
6.3 Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Application (2015-2026)

7 North America
7.1 North America Biosimilar Monoclonal Antibodies Market Size YoY Growth 2015-2026
7.2 North America Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
7.2.1 North America Biosimilar Monoclonal Antibodies Sales by Country (2015-2026)
7.2.2 North America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2026)
7.3 North America Biosimilar Monoclonal Antibodies Sales by Type
7.4 North America Biosimilar Monoclonal Antibodies Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Monoclonal Antibodies Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Facts & Figures by Region
8.2.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Region (2015-2026)
8.2.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2015-2026)
8.3 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Type
8.4 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Application
9 Europe
9.1 Europe Biosimilar Monoclonal Antibodies Market Size YoY Growth 2015-2026
9.2 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
9.2.1 Europe Biosimilar Monoclonal Antibodies Sales by Country (2015-2026)
9.2.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country (2015-2026)
9.3 Europe Biosimilar Monoclonal Antibodies Sales by Type
9.4 Europe Biosimilar Monoclonal Antibodies Sales by Application
10 Latin America
10.1 Latin America Biosimilar Monoclonal Antibodies Market Size YoY Growth 2015-2026
10.2 Latin America Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
10.2.1 Latin America Biosimilar Monoclonal Antibodies Sales by Country (2015-2026)
10.2.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2026)
10.3 Latin America Biosimilar Monoclonal Antibodies Sales by Type
10.4 Latin America Biosimilar Monoclonal Antibodies Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Biosimilar Monoclonal Antibodies Market Facts & Figures by Country
11.2.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2015-2026)
11.2.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2015-2026)
11.3 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type
11.4 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Biosimilar Monoclonal Antibodies Supply Chain Analysis
12.2 Biosimilar Monoclonal Antibodies Key Raw Materials and Upstream Suppliers
12.3 Biosimilar Monoclonal Antibodies Clients Analysis
12.4 Biosimilar Monoclonal Antibodies Sales Channel and Sales Model Analysis
12.4.1 Biosimilar Monoclonal Antibodies Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Biosimilar Monoclonal Antibodies Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Biosimilar Monoclonal Antibodies Distributors
13 Market Dynamics
13.1 Biosimilar Monoclonal Antibodies Market Drivers
13.2 Biosimilar Monoclonal Antibodies Market Opportunities
13.3 Biosimilar Monoclonal Antibodies Market Challenges
13.4 Biosimilar Monoclonal Antibodies Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables

Table 1. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 2. Major Manufacturers of Infliximab

Table 3. Major Manufacturers of Rituximab

Table 4. Major Manufacturers of Trastuzumab

Table 5. Major Manufacturers of Adalimumab

Table 6. Major Manufacturers of Other

Table 7. Global Biosimilar Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Biosimilar Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2026

Table 9. Global Biosimilar Monoclonal Antibodies Sales by Region (2015-2020) & (K Units)

Table 10. Global Biosimilar Monoclonal Antibodies Sales Forecast by Region (2021-2026) & (K Units)

Table 11. Global Biosimilar Monoclonal Antibodies Revenue by Region (2015-2020) & (US$ Million)

Table 12. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2021-2026) & (US$ Million)

Table 13. Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2015-2020) & (K Units)

Table 14. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturer (2015-2020)

Table 15. Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2015-2020) & (US$ Million)

Table 16. Biosimilar Monoclonal Antibodies Revenue Share by Manufacturer (2015-2020)

Table 17. Key Manufacturers Biosimilar Monoclonal Antibodies Price (2015-2020) & (USD/Unit)

Table 18. Ranking of Global Top Biosimilar Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2019

Table 19. Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)

Table 20. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2019)

Table 21. Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Biosimilar Monoclonal Antibodies Product Type

Table 23. Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Celltrion Corporation Information

Table 26. Celltrion Description and Business Overview

Table 27. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 28. Celltrion Biosimilar Monoclonal Antibodies Product

Table 29. Celltrion Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 30. Celltrion Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 31. Celltrion Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 32. Celltrion Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Sales Channel

Table 33. Celltrion Recent Development

Table 34. Pfizer (Hospira) Corporation Information

Table 35. Pfizer (Hospira) Description and Business Overview

Table 36. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 37. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product

Table 38. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 39. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 40. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 41. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Sales Channel

Table 42. Pfizer (Hospira) Recent Development

Table 43. 3SBIO Corporation Information

Table 44. 3SBIO Description and Business Overview

Table 45. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 46. 3SBIO Biosimilar Monoclonal Antibodies Product

Table 47. 3SBIO Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 48. 3SBIO Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 49. 3SBIO Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 50. 3SBIO Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Sales Channel

Table 51. 3SBIO Recent Development

Table 52. Novartis (Sandoz) Corporation Information

Table 53. Novartis (Sandoz) Description and Business Overview

Table 54. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 55. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product

Table 56. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 57. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 58. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 59. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Sales Channel

Table 60. Novartis (Sandoz) Recent Development

Table 61. Dr Reddy?s Corporation Information

Table 62. Dr Reddy?s Description and Business Overview

Table 63. Dr Reddy?s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 64. Dr Reddy?s Biosimilar Monoclonal Antibodies Product

Table 65. Dr Reddy?s Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 66. Dr Reddy?s Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 67. Dr Reddy?s Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 68. Dr Reddy?s Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Sales Channel

Table 69. Dr Reddy?s Recent Development

Table 70. Celgen Biopharma Corporation Information

Table 71. Celgen Biopharma Description and Business Overview

Table 72. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 73. Celgen Biopharma Biosimilar Monoclonal Antibodies Product

Table 74. Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 75. Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 76. Celgen Biopharma Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 77. Celgen Biopharma Recent Development

Table 78. Cadila Healthcare Corporation Information

Table 79. Cadila Healthcare Description and Business Overview

Table 80. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. Cadila Healthcare Biosimilar Monoclonal Antibodies Product

Table 82. Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 83. Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 84. Cadila Healthcare Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 85. Cadila Healthcare Recent Development

Table 86. Hisun Pharma Corporation Information

Table 87. Hisun Pharma Description and Business Overview

Table 88. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 89. Hisun Pharma Biosimilar Monoclonal Antibodies Product

Table 90. Hisun Pharma Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 91. Hisun Pharma Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 92. Hisun Pharma Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 93. Hisun Pharma Recent Development

Table 94. Torrent Pharmaceuticals Corporation Information

Table 95. Torrent Pharmaceuticals Description and Business Overview

Table 96. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 97. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product

Table 98. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Product

Table 99. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Application

Table 100. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Revenue (US$ Million) and Market Share by Geographic Area

Table 101. Torrent Pharmaceuticals Recent Development

Table 102. Global Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) & (K Units)

Table 103. Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2021-2026) & (K Units)

Table 104. Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020) & (US$ Million)

Table 105. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2021-2026) & (US$ Million)

Table 106. Global Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) & (K Units)

Table 107. Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2021-2026) & (K Units)

Table 108. Global Biosimilar Monoclonal Antibodies Revenue by Application (2015-2020) & (US$ Million)

Table 109. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2021-2026) & (US$ Million)

Table 110. North America Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) & (K Units)

Table 111. North America Biosimilar Monoclonal Antibodies Sales by Country (2021-2026) & (K Units)

Table 112. North America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) & (US$ Million)

Table 113. North America Biosimilar Monoclonal Antibodies Revenue by Country (2021-2026) & (US$ Million)

Table 114. North America Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) & (K Units)

Table 115. North America Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) & (K Units)

Table 116. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Region (2015-2020) & (K Units)

Table 117. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Region (2021-2026) & (K Units)

Table 118. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2015-2026) & (US$ Million)

Table 119. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2021-2026) & (US$ Million)

Table 120. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) & (K Units)

Table 121. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) & (K Units)

Table 122. Europe Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) & (K Units)

Table 123. Europe Biosimilar Monoclonal Antibodies Sales by Country (2021-2026) & (K Units)

Table 124. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) & (US$ Million)

Table 125. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2021-2026) & (US$ Million)

Table 126. Europe Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) & (K Units)

Table 127. Europe Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) & (K Units)

Table 128. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) & (K Units)

Table 129. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2021-2026) & (K Units)

Table 130. Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) & (US$ Million)

Table 131. Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2021-2026) & (US$ Million)

Table 132. Latin America Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) & (K Units)

Table 133. Latin America Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) & (K Units)

Table 134. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) & (K Units)

Table 135. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2021-2026) & (K Units)

Table 136. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) & (US$ Million)

Table 137. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2021-2026) & (US$ Million)

Table 138. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) & (K Units)

Table 139. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) & (K Units)

Table 140. Biosimilar Monoclonal Antibodies Key Raw Materials, Industry Status and Trend

Table 141. Biosimilar Monoclonal Antibodies Key Raw Materials and Upstream Suppliers

Table 142. Biosimilar Monoclonal Antibodies Clients Status and Trend

Table 143. Biosimilar Monoclonal Antibodies Typical Clients

Table 144. Biosimilar Monoclonal Antibodies Distributors

Table 145. Key Drivers: Impact Analysis (2021-2026)

Table 146. Biosimilar Monoclonal Antibodies Market Drivers

Table 147. Biosimilar Monoclonal Antibodies Market Opportunities

Table 148. Biosimilar Monoclonal Antibodies Market Challenges

Table 149. Biosimilar Monoclonal Antibodies Market Restraints

Table 150. Biosimilar Monoclonal Antibodies Porter?s Five Forces Analysis

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Biosimilar Monoclonal Antibodies Product Picture

Figure 2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020 & 2026

Figure 3. Infliximab Product Picture

Figure 4. Rituximab Product Picture

Figure 5. Trastuzumab Product Picture

Figure 6. Adalimumab Product Picture

Figure 7. Other Product Picture

Figure 8. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020 & 2026

Figure 9. Oncology Examples

Figure 10. Autoimmune Disease Examples

Figure 11. Other Examples

Figure 12. Biosimilar Monoclonal Antibodies Report Years Considered

Figure 13. Global Biosimilar Monoclonal Antibodies Market Size, (US$ Million), 2015 VS 2020 VS 2026

Figure 14. Global Biosimilar Monoclonal Antibodies Market Size 2015-2026 (US$ Million)

Figure 15. Global Biosimilar Monoclonal Antibodies Sales 2015-2026 (K Units)

Figure 16. Global Biosimilar Monoclonal Antibodies Market Size Market Share by Region: 2020 Versus 2026

Figure 17. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2015-2026)

Figure 18. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2026)

Figure 19. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturer in 2019

Figure 20. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2015-2026)

Figure 22. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2015-2026)

Figure 23. Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)

Figure 24. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2015-2026)

Figure 25. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Application (2015-2026)

Figure 26. Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)

Figure 27. North America Biosimilar Monoclonal Antibodies Revenue 2015-2026 (US$ Million)

Figure 28. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)

Figure 29. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

Figure 30. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue 2015-2026 (US$ Million)

Figure 31. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2026)

Figure 32. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2026)

Figure 33. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)

Figure 34. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

Figure 35. Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate 2015-2026 (US$ Million)

Figure 36. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2026)

Figure 37. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2026)

Figure 38. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)

Figure 39. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

Figure 40. Latin America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2015-2026 (US$ Million)

Figure 41. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2026)

Figure 42. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020)

Figure 43. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)

Figure 44. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

Figure 45. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate 2015-2026 (US$ Million)

Figure 46. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2026)

Figure 47. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2026)

Figure 48. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)

Figure 49. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

Figure 50. Biosimilar Monoclonal Antibodies Supply Chain (Upstream and Downstream Market)

Figure 51. Global Production Market Share of Biosimilar Monoclonal Antibodies Raw Materials by Region in 2019

Figure 52. Biosimilar Monoclonal Antibodies Distribution Channels

Figure 53. Global Biosimilar Monoclonal Antibodies Percentage 2015-2026: Indirect Sales VS Direct Sales

Figure 54. Global Biosimilar Monoclonal Antibodies Percentage 2015-2026: Online Sales VS Offline Sales

Figure 55. Porter's Five Forces Analysis

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

Celltrion

Pfizer (Hospira)

3SBIO

Novartis (Sandoz)

Dr Reddy?s

Celgen Biopharma

Cadila Healthcare

Hisun Pharma

Torrent Pharmaceuticals

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $4484

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase